Industry Spotlight  |
Biomarkers for Clinical Development

In Conversation With… Shuang Liang, Assistant Professor at UT Southwestern Medical Centre

Edited by Ben Norris |
17 November 2023
Here, we speak to UT Southwestern’s Shuang Liang about monitoring TREM2 as a non-invasive diagnostic biomarker for NASH.

Get your regular dose of industry news and announcements here, and keep up to date with the latest ‘Industry Spotlight’ posts. 

Visit our Biomarkers Portal to learn more about the latest research intspatial omics and its developmentsIf you’d like to register your interest for Oxford Global‘s upcoming Biomarkers UK conference, click here to download an agenda or register your interest.

How would you rate this content?

Share this article

Sign up for our monthly Biomarkers Newsletter

You may also be interested in...

Video Q&A
Here, we speak to Matthias von Herrath about Biomarkers US 2023 and some current trends in the industry concerning research and technological development.
20 November 2023
Industry Spotlight
A recent FNIH study demonstrates the effectiveness of non-invasive blood tests in diagnosing non-alcoholic steatohepatitis (NASH), potentially reducing the need for invasive liver biopsies and improving NASH diagnosis.
07 November 2023

Continue browsing

Share this article

Join our Biomarkers mailing list

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biomarkers